Policy | July 14, 2024
7th India-Japan medical product regulatory symposium held at New Delhi
Enhanced collaboration under the Memorandum of Cooperation (MoC) between India and Japan in medical product regulations
Enhanced collaboration under the Memorandum of Cooperation (MoC) between India and Japan in medical product regulations
The My Green Lab Certification is the gold standard for laboratory sustainability practices worldwide
Globally, colorectal cancer impacts 1.9 million people each year, standing as a leading cause of cancer mortality
This product will be manufactured at Lupin’s Pithampur facility in India
The approved ANDA is therapeutically equivalent to the reference listed drug product
Diroximel Fumarate Delayed-Release Capsules is indicated for the treatment of relapsing forms of multiple sclerosis
Dr. Roopal Thakkar joined Abbott/AbbVie in 2003 as part of the Physician Development Program
Olverembatinib, a novel drug developed by Ascentage Pharma with support from the National Major New Drug Development program
Utidelone can penetrate BBB due to its unique physicochemical characteristics and insusceptibility to P-glycoprotein-mediated efflux
Acquisition provides Ligand with the royalty rights to QARZIBA, a highly differentiated, commercial oncology drug marketed in 35 countries by global pharmaceutical company Recordati S.p.A.
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
